Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 11/11/2011
PIL Premique 0.625mg/5mg Coated Tablets.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 28/09/2011 and displayed until 11/11/2011
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 14/07/2011 and displayed until 28/09/2011
Reasons for adding or updating:
  • Change of contra-indications
Updated on 20/04/2010 and displayed until 14/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 25/01/2010 and displayed until 20/04/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 29/05/2009 and displayed until 25/01/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 29/08/2008 and displayed until 29/05/2009
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 24/06/2008 and displayed until 29/08/2008
Reasons for adding or updating:
  • Change to packaging
  • Change to storage instructions
Updated on 08/11/2006 and displayed until 24/06/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 10/02/2006 and displayed until 08/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to how the medicine works
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 14/04/2005 and displayed until 10/02/2006
Reasons for adding or updating:
  • Change from BAN to rINN
  • Change to storage instructions
  • Change to date of revision
Updated on 20/02/2004 and displayed until 14/04/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 19/11/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 08/07/2002 and displayed until 19/11/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   medroxyprogesterone acetate
   oestrogens, conjugated